Physician
Genesis Health System
Genesis Health System was paid $23.22M by Medicaid between Jan 2018 and Dec 2024, across 179 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 21% of everything it billed.
33Billing provider infoGENESIS HEALTH SYSTEM
DAVENPORT, IA 52804
DAVENPORT, IA 52804
33aNPI1477654945assigned 09/26/2006
33bProvider typeNeuromusculoskeletal Medicine & OMM Physician
28Total paid$23.22M
24GClaims653,950
24DCodes billed179
24AFirst – last monthJan 2018 – Dec 2024
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MALAS, JOSEPH controls 19+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 98,976 | $4.27M | |
| 2019 | 123,267 | $4.91M | |
| 2020 | 71,137 | $2.35M | |
| 2021 | 95,399 | $2.94M | |
| 2022 | 101,745 | $3.29M | |
| 2023 | 90,873 | $2.90M | |
| 2024incomplete | 72,553 | $2.57M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 21% | 135,757 | 128,122 | $4.79M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 17% | 80,710 | 75,156 | $3.88M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 9.8% | 31,062 | 29,843 | $2.27M |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 6.8% | 15,343 | 14,447 | $1.58M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.2% | 11,692 | 11,132 | $1.21M |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 5.2% | 26,634 | 25,178 | $1.21M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 5.0% | 26,046 | 24,935 | $1.16M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4.0% | 12,201 | 11,921 | $936K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 3.9% | 17,818 | 17,217 | $903K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.9% | 13,004 | 11,502 | $898K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.0% | 6,196 | 6,054 | $474K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.6% | 9,555 | 7,264 | $373K |
167 more codes
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.1% | 5,657 | $253K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 3,670 | $229K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 2,424 | $205K |
| 36415 | Collection of venous blood by venipuncture | <1% | 57,790 | $161K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 14,370 | $139K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 8,570 | $134K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 6,158 | $133K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 2,140 | $128K |
| 87634 | <1% | 1,370 | $107K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 10,553 | $104K |
| 90461 | <1% | 14,697 | $99K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 6,774 | $95K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 4,191 | $93K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 3,423 | $93K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 1,150 | $90K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 3,141 | $83K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 1,646 | $76K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 3,949 | $72K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 848 | $68K |
| 96127 | <1% | 4,924 | $64K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 696 | $63K |
| 0002A | <1% | 1,697 | $60K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 4,282 | $59K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 6,241 | $58K |
| 90686 | <1% | 10,432 | $58K | |
| 0001A | <1% | 1,764 | $53K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 2,263 | $50K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 4,266 | $48K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 484 | $44K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 2,148 | $39K |
| 81001 | <1% | 8,185 | $34K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 969 | $31K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 736 | $29K |
| 98926 | <1% | 889 | $21K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,314 | $21K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 340 | $20K |
| 90670 | <1% | 6,753 | $18K | |
| 73630 | <1% | 1,107 | $16K | |
| 99173 | <1% | 6,776 | $14K | |
| 87210 | <1% | 2,349 | $14K | |
| 81025 | <1% | 1,619 | $14K | |
| 99223 | Prolong inpt eval add15 m | <1% | 182 | $13K |
| 69210 | <1% | 350 | $12K | |
| 59025 | Fetal non-stress test | <1% | 464 | $12K |
| 73610 | <1% | 689 | $10K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 157 | $10K |
| 99220 | <1% | 104 | $10K | |
| 73562 | <1% | 649 | $10K | |
| 76830 | Ultrasound, transvaginal | <1% | 208 | $10K |
| 80061 | Lipid panel | <1% | 636 | $9K |
| 73130 | <1% | 613 | $9K | |
| 85018 | <1% | 3,032 | $9K | |
| 87420 | <1% | 546 | $9K | |
| 85027 | <1% | 1,207 | $8K | |
| 99479 | Subsequent intensive care, per day, very low birth weight infant | <1% | 74 | $8K |
| 90651 | <1% | 490 | $8K | |
| 99460 | <1% | 135 | $8K | |
| 0071A | <1% | 190 | $7K | |
| 0072A | <1% | 180 | $7K | |
| 95886 | <1% | 196 | $7K | |
| 72100 | <1% | 329 | $6K | |
| 81003 | <1% | 2,124 | $6K | |
| 90837 | Psychotherapy session, about an hour | <1% | 91 | $6K |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 211 | $6K |
| 80050 | General health panel | <1% | 126 | $5K |
| 80053 | Comprehensive metabolic panel | <1% | 401 | $5K |
| 91320 | <1% | 61 | $5K | |
| 99205 | Prolong outpt/office vis | <1% | 71 | $5K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 127 | $4K |
| 0003A | <1% | 117 | $4K | |
| 90480 | <1% | 134 | $4K | |
| 90677 | <1% | 1,002 | $4K | |
| 90734 | <1% | 371 | $4K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 47 | $4K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 242 | $4K |
| 90698 | <1% | 5,846 | $4K | |
| 99221 | <1% | 75 | $4K | |
| 90710 | <1% | 262 | $4K | |
| 90656 | <1% | 743 | $3K | |
| 99480 | Subsequent intensive care, per day, low birth weight infant | <1% | 30 | $3K |
| 86738 | <1% | 214 | $3K | |
| 85651 | <1% | 662 | $3K | |
| 36416 | <1% | 3,189 | $3K | |
| 73110 | <1% | 191 | $3K | |
| 85610 | <1% | 678 | $3K | |
| 90619 | <1% | 247 | $3K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 89 | $3K |
| 74018 | <1% | 187 | $3K | |
| 82044 | <1% | 439 | $3K | |
| 95912 | <1% | 31 | $3K | |
| 0004A | <1% | 61 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 144 | $2K |
| 73030 | <1% | 159 | $2K | |
| 94010 | <1% | 150 | $2K | |
| 82962 | <1% | 826 | $2K | |
| 99219 | <1% | 27 | $2K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 16 | $2K |
| 87081 | <1% | 231 | $2K | |
| 86308 | <1% | 243 | $2K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 351 | $2K |
| 3074F | <1% | 336 | $1K | |
| 99188 | <1% | 109 | $1K | |
| 94060 | <1% | 75 | $1K | |
| 54150 | <1% | 14 | $1K | |
| 99385 | <1% | 13 | $1K | |
| 94726 | <1% | 87 | $1K | |
| 90633 | <1% | 2,062 | $1K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 26 | $1K |
| 99384 | <1% | 12 | $1K | |
| 99307 | <1% | 145 | $1K | |
| 94760 | <1% | 791 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 117 | $1K |
| 3078F | <1% | 290 | $1K | |
| 94729 | <1% | 77 | $1K | |
| 90696 | <1% | 212 | $1K | |
| 92523 | <1% | 13 | $1K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 14 | $1K |
| 64615 | <1% | 12 | $992.40 | |
| 84439 | <1% | 110 | $977.40 | |
| 3079F | <1% | 157 | $866.76 | |
| 85652 | <1% | 229 | $835.04 | |
| 90621 | <1% | 35 | $817.31 | |
| 20611 | <1% | 15 | $638.25 | |
| 99217 | <1% | 12 | $637.03 | |
| 81000 | <1% | 165 | $611.07 | |
| 90715 | <1% | 209 | $604.59 | |
| 83655 | <1% | 37 | $602.69 | |
| 73502 | <1% | 25 | $551.40 | |
| 3075F | <1% | 93 | $467.54 | |
| 0124A | <1% | 14 | $448.80 | |
| 99442 | <1% | 12 | $436.92 | |
| 90716 | <1% | 132 | $392.92 | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 32 | $386.24 |
| 3044F | <1% | 50 | $343.77 | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 24 | $340.16 |
| 0011A | <1% | 20 | $334.32 | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 13 | $322.44 |
| 90707 | <1% | 108 | $301.59 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 16 | $269.90 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 24 | $231.04 |
| 71100 | <1% | 14 | $229.42 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 13 | $206.81 |
| 99406 | <1% | 62 | $196.10 | |
| 90685 | <1% | 233 | $189.57 | |
| 73140 | <1% | 15 | $160.85 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 49 | $157.77 |
| 3077F | <1% | 26 | $124.18 | |
| 81002 | <1% | 25 | $62.28 | |
| T1015 | A visit at a community health center or clinic (one all-in rate) | <1% | 28 | $54.74 |
| 99490 | Ccm add 20min | <1% | 13 | $39.02 |
| 90744 | <1% | 1,613 | $31.83 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 16 | $7.20 |
| 90680 | <1% | 3,838 | $0.47 | |
| 99075 | 0% | 33 | $0.00 | |
| 90662 | 0% | 31 | $0.00 | |
| 90672 | 0% | 20 | $0.00 | |
| 91300 | 0% | 521 | $0.00 | |
| 90700 | 0% | 12 | $0.00 | |
| 91312 | 0% | 44 | $0.00 | |
| 90681 | 0% | 94 | $0.00 | |
| 3008F | 0% | 511 | $0.00 | |
| 90697 | 0% | 875 | $0.00 | |
| 3080F | 0% | 14 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 75 | $0.00 |
| 91307 | 0% | 374 | $0.00 | |
| 91305 | 0% | 31 | $0.00 | |
| 90647 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMALAS, JOSEPH (VICE PRESIDENT OF FINANCE)
| Provider | Location | Paid |
|---|---|---|
| Mercy Health System Corporation | Janesville, WI | $25.46M |
| Mercy Health System Corporation | Janesville, WI | $13.19M |
| Mercy Health System Corporation | Lake Geneva, WI | $9.39M |
| Mercy Health System Corporation | Janesville, WI | $8.15M |
| Mercy Assisted Care, INC | Janesville, WI | $4.04M |
| Genesis Medical Center, Aledo | Aledo, IL | $3.62M |
| Freeport Memorial Hospital | Freeport, IL | $1.40M |
| Javon Bea Hospital | Rockford, IL | $1.23M |
| Mercy Health System Corporation | Janesville, WI | $1.17M |
| Mercy Assisted Care, INC | Harvard, IL | $601K |
| Mercyhealth Visiting Nurses Association, INC | Rockford, IL | $251K |
| Javon Bea Hospital | Rockford, IL | $174K |
| Genesis Health System | De Witt, IA | $136K |
| Mercy Assisted Care, INC | Janesville, WI | $136K |
| Genesis Health System | Bettendorf, IA | $32K |
| Mercy Assisted Care, INC | Janesville, WI | $12K |
| Mercy Harvard Hospital INC | Harvard, IL | $10K |
| Rockford Health Physicians | Rockford, IL | $9K |
| Mercy Health System Corporation | Janesville, WI | $1K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.